An official website of the United States government
Publication Information
Affiliation
Department of Pediatrics, Section of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Colorado Denver School of Medicine and the Children's Hospital, Aurora, CO 80045, USA. narkewicz.michael@tchden.org
Authors
Balistreri W, Barton BA, Billote GB, Brown KM, Chen K, Doo E, Drack A, Duggan C, Fauchere S, Ferayorni L, Garrett B, Gonzalez-Peralta RP, Goodman ZD, Haber B, Hawkins A, Hodik M, Hoofnagle JH, Jonas M, Klipsch A, Lieb W, Lobritto S, Margolis T, McCarthy M, Mocilnikar C, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Newman-Georges JO, PEDS-C Study Group, Repka MX, Robuck PR, Rosenthal P, Roy A, Schwarz KB, Senz H, Torrance R, Young ML
Studies
Citation
Narkewicz MR, Rosenthal P, Schwarz KB, Drack A, Margolis T, Repka MX, PEDS-C Study Group. Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferon. J Pediatr Gastroenterol Nutr 2010 Aug;51(2):183-6.Abstract
Interferon treatment for chronic viral hepatitis C (HCV) has been associated with the development of retinopathy in 19% to 29% of adults. Our purpose is to describe the ophthalmologic complications of pegylated interferon-alpha2a with either placebo or ribavirin in children with chronic HCV (the PEDS-C trial).